Markets

Merxin designs and supplies device platforms to 3 main markets; Pharmaceutical drug delivery, Reduced Risk Nicotine Inhalers (RiNih) and Inhaled cannabinoids therapies (iCTx).

Merxin MRX004 Inhalation

Pharmaceutical

The pharmaceuticals market is Merxin’s native land. The team at Merxin has been working in and for the pharmaceutical industry for decades, designing devices, formulations, planning clinical studies and filings for the treatment of Asthma, COPD, IPAH, cystic fibrosis etc...

LEARN MORE

Reduced Risk Nicotine Inhalers (RiNih)

Vaping devices have opened the world to Reduced Risk Nicotine Inhalers (RiNih). Inhalers that avoid the carcinogenic compounds found in combustion cigarettes while retaining the sensory experience are sought by smokers and vapers...

LEARN MORE
Reduced Risk Nicotine Inhaler
MRX001 Inhalation

Cannabinoids

Our body would not function were it not for its endocannabinoid system. Cannabis and its derivatives are now being brought back to the natural pharmacopeia...

LEARN MORE
" We believe in quality and deliver reliability "
We use cookies only for marketing analytics
Close